Report Publication Announcement • Apr 8, 2009
Report Publication Announcement
Open in ViewerOpens in native device viewer
Contact: SE-753 18 Uppsala Torben Jörgensen, President and CEO Tel+46 18 56 59 00 Tel: +46 707 49 05 84, [email protected] www.biotage.com
Kungsgatan 76
Uppsala April 8, 2009
Biotage is today releasing its 2008 annual report.
The company generated net sales of 385,3 MSEK (397,6 MSEK).
The operating result amounted to 22,5 MSEK (16,7 MSEK) and total profit after tax for the year of 299,1 MSEK (99,4 MSEK).
Total profit per share of 3,38 SEK (1,12 SEK).
Biotage business is under changes after the divestment of the Biosystems business and the ongoing restructuring of the remaining Discovery Chemistry business. The decision to close down the factory in Charlottesville, Virigina, and to outsource the manufacturing of Biotage's instrument, results in relatively big organizational and operational changes. By reason hereof new more specific financial goals will be set during the latter part of 2009, when the effects from the ongoing changes may be measured more in detail. Short term Biotage will adjust the organization to the new conditions and will re-establish organic growth in the business. At the same time Biotage will profit from its strong financial position and seek to acquire attractive businesses or products.
The full report is available at: Annual Report 2008
About Biotage
Biotage is a global company active in life science research with strong technologies, a broad range of operations and a long-term view of the market. The company offers solutions, knowledge and experience in the area of medicinal chemistry. In 2005 business and products from the company Argonaut were acquired, further strengthening the product range in medicinal chemistry. The customers include the worlds top 30 pharma companies, the worlds top 20 biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the U.S., Japan, UK, Germany and several other European countries. Biotage has 300 employees and had sales of 385,3 MSEK in 2008. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.